Before the 1920s, a diagnosis of diabetes mellitus was essentially a death sentence, particularly for children, who rarely survived beyond a year. Treatment options were severely limited, often involving extreme dietary restrictions that merely prolonged suffering without offering a cure. It was in this bleak context that Frederick Banting, a young surgeon from Ontario, conceived a revolutionary idea. He hypothesized that a specific secretion from the pancreas, if isolated, could regulate blood sugar. His theory challenged prevailing views, suggesting that the digestive enzymes produced by the pancreas were destroying the anti-diabetic substance before it could be extracted. This bold insight laid the groundwork for his future groundbreaking research.

In 1921, Banting presented his radical hypothesis to Professor John Macleod at the University of Toronto. Initially skeptical, Macleod eventually provided Banting with laboratory space, ten dogs, and the assistance of Charles Best, a medical student, for the summer. Their early experiments involved ligating the pancreatic ducts of dogs, causing the enzyme-producing cells to degenerate, thereby allowing the 'islet' cells to secrete their extract undisturbed. Despite rudimentary facilities and initial setbacks, Banting and Best painstakingly refined their extraction methods. Their persistence led to the isolation of a substance from the degenerated pancreases that significantly lowered blood glucose levels in diabetic dogs, offering the first tangible proof of Banting's theory.

The promising results from animal trials necessitated a more refined extract suitable for human use. This crucial purification step was undertaken by James Collip, a biochemist, who joined the team in December 1921. Collip developed a process to purify the pancreatic extract, making it safe and effective for clinical application. The first human trial occurred on January 11, 1922, when a 14-year-old diabetic patient named Leonard Thompson received an injection. While the initial extract caused an allergic reaction, Collip's subsequent refinement led to a second, successful injection 12 days later, dramatically improving Thompson's condition and proving the extract's therapeutic potential in humans. This marked a pivotal moment in medical history.

The successful isolation and purification of insulin rapidly transformed diabetes care worldwide. The University of Toronto, recognizing the immense public health implications, refused to patent insulin for profit, opting instead for widespread accessibility. They licensed the production to pharmaceutical companies like Eli Lilly, ensuring that the life-saving treatment could be mass-produced and distributed globally. In recognition of their monumental achievement, Banting and Macleod were awarded the Nobel Prize in Physiology or Medicine in 1923. Banting, however, shared his prize money with Best, and Macleod shared his with Collip, acknowledging the collaborative nature of this scientific breakthrough that has saved millions of lives.

Not Given